What role does G-CSF (Granulocyte Colony Stimulating Factor) play in chemotherapy management?

What role does G-CSF (Granulocyte Colony Stimulating Factor) play in chemotherapy management?

• A. It inhibits the growth of cancer cells
• B. It stimulates the production of neutrophils
• C. It enhances red blood cell production
• D. It lowers blood sugar levels

Answer: (B)

Granulocyte Colony Stimulating Factor (G-CSF) plays a crucial role in the management of chemotherapy, particularly in mitigating one of the significant side effects of chemotherapy: neutropenia, which is a decrease in neutrophils (a type of white blood cell). During chemotherapy, the bone marrow can be suppressed, resulting in reduced production of neutrophils, leading to increased susceptibility to infections. G-CSF works by stimulating the bone marrow to produce more neutrophils, thereby helping to normalize their levels in the blood. This stimulation of neutrophil production is vital for patients undergoing chemotherapy, as it can help reduce the risk of infection and facilitate the continuation of cancer treatment. In summary, G-CSF's primary function in this context is to enhance neutrophil production, making option B the correct choice. The other options are unrelated to G-CSF's function in chemotherapy management. G-CSF does not directly inhibit cancer cell growth, enhance red blood cell production, or lower blood sugar levels, which are functions associated with other medications or biological processes.

Granulocyte Colony Stimulating Factor (G-CSF) plays a crucial role in the management of chemotherapy, particularly in mitigating one of the significant side effects of chemotherapy: neutropenia, which is a decrease in neutrophils (a type of white blood cell). During chemotherapy, the bone marrow can be suppressed, resulting in reduced production of neutrophils, leading to increased susceptibility to infections. G-CSF works by stimulating the bone marrow to produce more neutrophils, thereby helping to normalize their levels in the blood.

This stimulation of neutrophil production is vital for patients undergoing chemotherapy, as it can help reduce the risk of infection and facilitate the continuation of cancer treatment. In summary, G-CSF's primary function in this context is to enhance neutrophil production, making option B the correct choice.

The other options are unrelated to G-CSF's function in chemotherapy management. G-CSF does not directly inhibit cancer cell growth, enhance red blood cell production, or lower blood sugar levels, which are functions associated with other medications or biological processes.